scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1013269463 |
P356 | DOI | 10.1186/BCR1013 |
P932 | PMC publication ID | 1143561 |
P698 | PubMed publication ID | 15987434 |
P5875 | ResearchGate publication ID | 7757378 |
P50 | author | Ann Aschengrau | Q43184014 |
P2093 | author name string | Brian D Bradbury | |
Jemma B Wilk | |||
Timothy L Lash | |||
P2860 | cites work | Perchloroethylene-contaminated drinking water and the risk of breast cancer: additional results from Cape Cod, Massachusetts, USA | Q24813464 |
Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression | Q28116125 | ||
N-acetyltransferase | Q28270778 | ||
Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver | Q33190344 | ||
Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver | Q33493879 | ||
Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms | Q33833591 | ||
Epidemiological methods for studying genes and environmental factors in complex diseases | Q34421625 | ||
DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke. | Q34637005 | ||
Tobacco and cancer: epidemiology and the laboratory | Q34834385 | ||
Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis | Q34914587 | ||
Cigarette smoking and the risk of breast cancer in women: a review of the literature | Q34958954 | ||
Nucleotide sequence of an intronless gene for a human arylamine N-acetyltransferase related to polymorphic drug acetylation | Q35228461 | ||
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity | Q35643631 | ||
Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group | Q36079437 | ||
Molecular mechanism of slow acetylation of drugs and carcinogens in humans | Q37532218 | ||
Diverse point mutations in the human gene for polymorphic N-acetyltransferase | Q37552468 | ||
Acetylator genotype and arylamine-induced carcinogenesis | Q39653636 | ||
Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus | Q40406973 | ||
Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. | Q40530680 | ||
Toward a physiological approach to breast cancer prevention. | Q40689523 | ||
Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. | Q40857024 | ||
Cigarette smoking and the risk of breast cancer | Q40862130 | ||
Molecular epidemiology of breast cancer. | Q41435039 | ||
Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. | Q44012104 | ||
NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women | Q44497812 | ||
Preliminary phenotypic map of chromosome 4p16 based on 4p deletions. | Q45992148 | ||
Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases | Q50336069 | ||
Relation of breast cancer with passive and active exposure to tobacco smoke. | Q52887337 | ||
Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. | Q54261668 | ||
Active and Passive Cigarette Smoking and the Occurrence of Breast Cancer | Q57240454 | ||
A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer | Q57982063 | ||
Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens | Q59094252 | ||
Passive and active smoking and breast cancer risk in Canada, 1994-97 | Q64130676 | ||
The effect of misclassification in the presence of covariates | Q71347668 | ||
NAT2*12A (803A-->G) codes for rapid arylamine n-acetylation in humans | Q71533220 | ||
Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk | Q71748553 | ||
Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans | Q72228915 | ||
Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype | Q74136959 | ||
Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk | Q74578010 | ||
Limitations of the case-only design for identifying gene-environment interactions | Q74599234 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tobacco smoke | Q2386268 |
P304 | page(s) | R385-93 | |
P577 | publication date | 2005-03-21 | |
P1433 | published in | Breast Cancer Research | Q2208481 |
P1476 | title | A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology. | |
P478 | volume | 7 |
Q37440644 | Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations |
Q35353824 | Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study |
Q37434505 | N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women. |
Q36838165 | Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5. |